TEVA PHARMACEUTICAL 1 By Ryan Moore Sec. 6 “We Make Quality Healthcare Accessible Around The World” 9/21/11 If you click on the red arrow, you will skip to a view of Teva’s stock chart
Transcript
Slide 1
Slide 2
1 Sec. 69/21/11 If you click on the red arrow, you will skip to
a view of Tevas stock chart
Slide 3
As a worldwide generic pharmaceuticals leader, Teva is one of
the top 15 pharmaceutical companies in the world. Its headquarters
are located in Israel while Teva has operations within 60 other
countries and carrys a collection of 42,000 employees worldwide.
Teva takes great pride in its long tradition of leadership and
dedication to excellence in service; originating from the companys
founding year in 1901. 09/21/11Ryan Moore CIS 10552
Slide 4
Branded products are categorized into CNS (Central Nervous
System) products, Respiratory products, Womens Health products, and
BioSimilars products. Teva's CNS products include COPAXONE
(glatiramer acetate injection), the world's top selling treatment
for relapsing-remitting multiple sclerosis (RRMS), and
AZILECT(rasagiline tablets), a treatment for Parkinson's disease.
Teva's high-quality treatment options for people with respiratory
disorders are designed to accommodate patients' preferences and
improve convenience and ease of use. Teva is committed to help
women live better, healthier and longer lives. We develop effective
drugs, products and interventional medical treatments that benefit
women throughout their lifecycle. Teva aspires to broaden the
access to life saving biologic treatments, making them available
and obtainable for more people around the world. Other than Teva
owning branded products, it is also the No. 1 generic company in
the world. 63 Billion tablets and capsules were manufactured in
2010 and there has been over 600 million prescriptions affiliated
with Teva. 09/21/11Ryan Moore CIS 10553
Slide 5
09/21/11Ryan Moore CIS 10554 1 Production begins according to
GMP (Good Manufacturing Practice) regulations to ensure the
absolute highest standards of quality. 2 Once production is
completed, products are distributed to Teva's customers around the
world including; pharmacies and pharmacy chains, hospitals,
health-insurers, wholesalers and more. 3 Teva's vast supply chain
once again succeeds in meeting the most challenging deadlines by
land, sea, or air.
Slide 6
Teva comments on Supreme Court Decision - 6/23/2011 Teva is
pleased with the High Court's decision today, which provides great
clarity for both the drug industry as well as patients. Teva Signs
$4 Billion Syndicated Credit Facilities - 6/13/2011 Teva
Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that
it has entered into Syndicated Credit Facilities totaling $4
billion supporting the $6.8 billion acquisition of Cephalon, Inc.
Teva Announces Launch of Camrese - 7/28/2011 Teva Pharmaceuticals
USA, the U.S.based generic arm of Teva Pharmaceuticals announced
that it will sell Camrese as the Authorized Generic of Seasonique
which is also manufactured by Teva Pharmaceuticals. This product
will continue to be manufactured under the brand products new drug
application or NDA at the same facility where it is currently
produced. 09/21/11Ryan Moore CIS 10555
Slide 7
Balance Sheet (at a glance) in Millions Sales by Channel [ Drug
store chains - 54% of net sales Drug wholesalers - 33% of net sales
Managed care organizations - 6% of net sales Generic distributors -
6% of net sales Governmental facilities and others - 1% of net
sales Business Growth - FY 2009 (ended December 31, 2009) Net sales
increased 25% to $13.9 billion. Net income more than doubled to $2
billion, compared to $609 million in the previous year.
09/21/11Ryan Moore CIS 10556
Slide 8
09/21/11Ryan Moore CIS 10557 Investment is part of Teva's
strategy to expand its branded activities into specialty
therapeutic areas. If Tevas stock chart is clicked, you will be
taken back to the first slide of the presentation.
Slide 9
Organizational Hierarchy President and CEO Schlomo Yanai Chief
Financial Officer Eyal Desheh Corporate Vice President/Chief Legal
Officer/Company Secretary Richard S. Egosi Corporate Vice
President/Head of Business Development Prof. Itzhak Krinsky HR and
Chief Integration Officer Ika (Issac) Abravanel 09/21/11Ryan Moore
CIS 10558 Organizational Structure Teva's organizational structure
is an emblem of Teva's fundamental business strategy, highlighting
our global strength and our pharmaceutical diversity. It enables us
to continue to expand our core generic business across all
geographies and leverage our global reach and scientific strength
to develop new innovative products and technologies.
Slide 10
Visit the companys main webpage http://www.tevapharm.com in
order to discover more information and enter an in depth look into
the workings behind the success of Teva. http://www.tevapharm.com
Also visit http://finance.yahoo.com/q?s=TEVA or
http://www.hoovers.com/company/Teva_Pharm
aceuticals_USA/rrrsyhi-1.html for stock and financial information
about Teva Pharmecudical Works.http://finance.yahoo.com/q?s=TEVA
http://www.hoovers.com/company/Teva_Pharm
aceuticals_USA/rrrsyhi-1.html 09/21/11Ryan Moore CIS 10559 (Works
Cited)